FI69453C - Saett att framstaella en ny polymorf form av terapeutiskt anvaendbar 2-(4-klorfenyl)-alfa-metyl-5-bensoxazolylaettiksyra - Google Patents
Saett att framstaella en ny polymorf form av terapeutiskt anvaendbar 2-(4-klorfenyl)-alfa-metyl-5-bensoxazolylaettiksyra Download PDFInfo
- Publication number
- FI69453C FI69453C FI782043A FI782043A FI69453C FI 69453 C FI69453 C FI 69453C FI 782043 A FI782043 A FI 782043A FI 782043 A FI782043 A FI 782043A FI 69453 C FI69453 C FI 69453C
- Authority
- FI
- Finland
- Prior art keywords
- methyl
- chlorophenyl
- polymorf
- benzozazolyl
- alphate
- Prior art date
Links
- GEAXLHPORCRESC-UHFFFAOYSA-N chlorocyclohexatriene Chemical class ClC1=CC=C=C[CH]1 GEAXLHPORCRESC-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 claims description 24
- 229960005430 benoxaprofen Drugs 0.000 claims description 10
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 101100340774 Xenopus laevis ilf3-a gene Proteins 0.000 claims 1
- 101150040667 ilf3 gene Proteins 0.000 claims 1
- 239000013078 crystal Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI831930A FI69454C (fi) | 1977-06-28 | 1983-05-30 | Saett att framstaella en termodynamiskt stabil ny polymorf form av terapeutiskt anvaendbar 2-(4-klorfenyl)-alfa-metyl-5-bensoxazolylaettiksyra |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2690777 | 1977-06-28 | ||
| GB26907/77A GB1590587A (en) | 1977-06-28 | 1977-06-28 | Benoxaprofen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI782043A7 FI782043A7 (fi) | 1978-12-29 |
| FI69453B FI69453B (fi) | 1985-10-31 |
| FI69453C true FI69453C (fi) | 1986-02-10 |
Family
ID=10251100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI782043A FI69453C (fi) | 1977-06-28 | 1978-06-27 | Saett att framstaella en ny polymorf form av terapeutiskt anvaendbar 2-(4-klorfenyl)-alfa-metyl-5-bensoxazolylaettiksyra |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0000276B1 (cs) |
| JP (1) | JPS5411224A (cs) |
| AT (1) | AT360008B (cs) |
| AU (1) | AU518403B2 (cs) |
| BE (1) | BE868522A (cs) |
| CH (1) | CH631449A5 (cs) |
| DE (2) | DE2828074A1 (cs) |
| DK (1) | DK145419C (cs) |
| FI (1) | FI69453C (cs) |
| FR (1) | FR2396004A1 (cs) |
| GB (1) | GB1590587A (cs) |
| IE (1) | IE47009B1 (cs) |
| IL (1) | IL55015A (cs) |
| IT (1) | IT1105065B (cs) |
| LU (1) | LU79879A1 (cs) |
| NZ (1) | NZ187674A (cs) |
| ZA (1) | ZA783660B (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1435721A (en) * | 1972-05-18 | 1976-05-12 | Lilly Industries Ltd | Benzoxazole derivatives |
| US3888864A (en) | 1973-06-29 | 1975-06-10 | Hoffmann La Roche | Amino lower alkyl ether derivatives of opium alkaloids |
| GB1495488A (en) * | 1976-06-23 | 1977-12-21 | Ippco Int Pharma Patents Co Es | Optically active 2-(2-phenyl-5-benzoxazolyl)propionic acids |
| IT1099589B (it) * | 1978-08-04 | 1985-09-18 | Ravizza Spa | Processo per la preparazione di derivati dell'acido benzoxazolil propionico |
| IT1157295B (it) * | 1982-07-19 | 1987-02-11 | Ravizza Spa | Processo perfezionato per la preparazione di derivati dell'acido benzoxazolil propionico |
| UA83620C2 (ru) | 2001-12-05 | 2008-08-11 | Уайт | Замещенные бензоксазолы и их аналоги как эстрогенные агенты |
| WO2021116820A1 (en) * | 2019-12-10 | 2021-06-17 | Aurobindo Pharma Limited | An improved process for the preparation of benoxaprofen |
| DE102022117931A1 (de) | 2022-07-18 | 2024-01-18 | HUECK System GmbH & Co. KG | Profilanordnung mit wärmedämmung |
| US11981645B1 (en) | 2023-10-10 | 2024-05-14 | King Faisal University | N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as antimicrobial compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1435721A (en) * | 1972-05-18 | 1976-05-12 | Lilly Industries Ltd | Benzoxazole derivatives |
| GB1488003A (en) * | 1973-10-23 | 1977-10-05 | Lilly Industries Ltd | 1,2-benzisoxazole derivatives processes for their preparation and their use as pharmaceuticals |
| US4087437A (en) * | 1976-09-07 | 1978-05-02 | Eli Lilly And Company | 2-Phenyl-5-benzoxazolylalkanoic acid purification process |
-
1977
- 1977-06-28 GB GB26907/77A patent/GB1590587A/en not_active Expired
-
1978
- 1978-06-26 CH CH691778A patent/CH631449A5/fr not_active IP Right Cessation
- 1978-06-26 NZ NZ187674A patent/NZ187674A/xx unknown
- 1978-06-26 DK DK287578A patent/DK145419C/da not_active IP Right Cessation
- 1978-06-27 ZA ZA00783660A patent/ZA783660B/xx unknown
- 1978-06-27 JP JP7795178A patent/JPS5411224A/ja active Granted
- 1978-06-27 AT AT466178A patent/AT360008B/de not_active IP Right Cessation
- 1978-06-27 BE BE6046515A patent/BE868522A/xx not_active IP Right Cessation
- 1978-06-27 IE IE1277/78A patent/IE47009B1/en not_active IP Right Cessation
- 1978-06-27 LU LU79879A patent/LU79879A1/xx unknown
- 1978-06-27 FR FR7819091A patent/FR2396004A1/fr active Granted
- 1978-06-27 EP EP78300082A patent/EP0000276B1/en not_active Expired
- 1978-06-27 FI FI782043A patent/FI69453C/fi not_active IP Right Cessation
- 1978-06-27 DE DE19782828074 patent/DE2828074A1/de not_active Ceased
- 1978-06-27 IT IT50048/78A patent/IT1105065B/it active
- 1978-06-27 IL IL55015A patent/IL55015A/xx unknown
- 1978-06-27 AU AU37501/78A patent/AU518403B2/en not_active Expired
- 1978-06-27 DE DE7878300082T patent/DE2862013D1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ATA466178A (de) | 1980-05-15 |
| BE868522A (fr) | 1978-12-27 |
| JPS5411224A (en) | 1979-01-27 |
| CH631449A5 (fr) | 1982-08-13 |
| FR2396004A1 (fr) | 1979-01-26 |
| EP0000276A1 (en) | 1979-01-10 |
| NZ187674A (en) | 1980-11-14 |
| DK145419B (da) | 1982-11-15 |
| JPS6231714B2 (cs) | 1987-07-09 |
| ZA783660B (en) | 1979-06-27 |
| DE2862013D1 (en) | 1982-10-28 |
| FI69453B (fi) | 1985-10-31 |
| AU518403B2 (en) | 1981-10-01 |
| LU79879A1 (cs) | 1978-12-07 |
| DK145419C (da) | 1983-04-18 |
| DE2828074A1 (de) | 1979-01-11 |
| IE47009B1 (en) | 1983-11-30 |
| DK287578A (da) | 1978-12-29 |
| AU3750178A (en) | 1980-01-03 |
| IT7850048A0 (it) | 1978-06-27 |
| IT1105065B (it) | 1985-10-28 |
| GB1590587A (en) | 1981-06-03 |
| IE781277L (en) | 1978-12-28 |
| IL55015A (en) | 1981-11-30 |
| AT360008B (de) | 1980-12-10 |
| IL55015A0 (en) | 1978-08-31 |
| FR2396004B1 (cs) | 1981-09-18 |
| FI782043A7 (fi) | 1978-12-29 |
| EP0000276B1 (en) | 1982-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI82189C (fi) | Foerfarande foer framstaellning av en stabil modifikation av torasemid. | |
| FI69453B (fi) | Saett att framstaella en ny polymorf form av terapeutiskt anvaendbar 2-(4-klorfenyl)-alfa-metyl-5-bensoxazolylaettiksyra | |
| KR101015034B1 (ko) | 브롬화물 및 이의 결정 | |
| Nadeem et al. | Synthesis and in vitro biological activities of 4, 5-disubstituted 1, 2, 4-triazole-3-thiols | |
| WO2021000687A1 (zh) | Pac-1晶型的制备方法 | |
| CN102993179A (zh) | 一种高纯度雷贝拉唑钠的制备方法 | |
| EP3322709B1 (en) | Crystalline forms of (3r)-3-cyclopentyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile salts and preparation thereof | |
| Guimaraes et al. | Naphthoquinone-based hydrazone hybrids: synthesis and potent activity against cancer cell lines | |
| RU2648990C1 (ru) | Кристаллы лобаплатина, способы получения и применения в фармацевтике | |
| WO2021023194A1 (zh) | 吡嗪-2(1h)-酮类化合物的c晶型和e晶型及其制备方法 | |
| CN103012401B (zh) | 蒽醌多吡啶配体及钌-蒽醌配合物的制备方法和应用 | |
| CN110862396B (zh) | 一种吡咯并[3,4-c]咔唑-1,3(2H，6H)-二酮类化合物的合成方法 | |
| EP3872072A1 (en) | Crystal form of maleate of tyrosine kinase inhibitor and preparation method therefor | |
| CN104140414B (zh) | 阿昔替尼晶型的制备方法 | |
| CN105992769B (zh) | 一种钠-葡萄糖协同转运蛋白2抑制剂的l-脯氨酸复合物、其一水合物及晶体 | |
| KR20110107237A (ko) | 에피루비신 염산염의 신규한 결정형 | |
| KR101414888B1 (ko) | 1-(2'-시아노-2'-데옥시-β-Ｄ-아라비노푸라노실)시토신·1염산염의 신규 안정형 결정 | |
| JP2663105B2 (ja) | １４α−ヒドロキシ−４−アンドロステン−３，６，１７−トリオン水和物結晶及びその製造法 | |
| CN105646320A (zh) | 一种稳定的维纳卡兰化合物 | |
| GB2097791A (en) | Quaternary ammonium salt | |
| Garg et al. | Reactive Methylene Compounds. I. Synthesis of Some Pyrazoles. | |
| CN116354967A (zh) | 一种核苷化合物的晶型及其制备方法和应用 | |
| EP3704109B1 (en) | Process for the preparation of the crystalline form iii of tipiracil hydrochloride | |
| CN111689961A (zh) | 一种利奧西呱的新晶型及其制备方法 | |
| FI69454B (fi) | Saett att framstaella en termodynamiskt stabil ny polymorf form av terapeutiskt anvaendbar 2-(4-klorfenyl)-alfa-metyl-5-bensoxazolylaettiksyra |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: LILLY INDUSTRIES LIMITED |